Company Profiles

driven by the PitchBook Platform

Avraham Pharmaceuticals

Description

Developer of products for treatment and prevention of neurodegenerative disorders. The company's product, Ladostigil, provides a drug candidate for treatment of Alzheimer’s Disease in patients diagnosed with Mild Cognitive Impairment(MCI).

2010

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$4M

Latest Deal Amount

$26.2M

Total Amount Raised

7

Investors

Description

Developer of products for treatment and prevention of neurodegenerative disorders. The company's product, Ladostigil, provides a drug candidate for treatment of Alzheimer’s Disease in patients diagnosed with Mild Cognitive Impairment(MCI).

Website:

www.avphar.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

42 Hayarkon street Northern Industrial Zone Yavneh 81227Israel +972 (0)8 932 4000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Avraham Pharmaceuticals's full profile, request a free trial.

Avraham Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Avraham Pharmaceuticals Investors (7)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Clal Biotechnology IndustriesVenture CapitalMinority000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Integra HoldingsVenture CapitalMinority000 0000000 0000
Integra LifesciencesCorporationMinority000 0000000 0000
Pontifax Venture CapitalVenture CapitalMinority000 0000000 0000
Clal Biotechnology Industries Venture Capital
Individual Investor Angel (individual)
Integra Holdings Venture Capital
Integra Lifesciences Corporation
Pontifax Venture Capital Venture Capital

Avraham Pharmaceuticals Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Yona Geffen Ph.DChief Executive Officer
Moti HachamChief Financial Officer
Marta Weinstock-Rosin Ph.DBoard Member and Scientific Co-Founder
Michael Chorev Ph.DScientific Co-Founder
Moussa YoudimScientific Co-Founder
Yona Geffen Ph.D Chief Executive Officer
Moti Hacham Chief Financial Officer
Marta Weinstock-Rosin Ph.D Board Member and Scientific Co-Founder
Michael Chorev Ph.D Scientific Co-Founder
Moussa Youdim Scientific Co-Founder

Avraham Pharmaceuticals Board Members (5)

NameRepresentingRoleSinceContact
Info
Marta Weinstock-Rosin Ph.DAvraham PharmaceuticalsBoard Member and Scientific Co-Founder000 0000
Ofer GonenSelfBoard Member000 0000
Tomer Kariv JDPontifax Venture CapitalCo-Founder & Chief Executive Officer000 0000
Yaacov MichlinSelfChairman000 0000
Yigal KoltinSelfBoard Member000 0000
Marta Weinstock-Rosin Ph.D Board Member and Scientific Co-Founder Avraham Pharmaceuticals
Ofer Gonen Board Member Self
Tomer Kariv JD Co-Founder & Chief Executive Officer Pontifax Venture Capital
Yaacov Michlin Chairman Self
Yigal Koltin Board Member Self
Request full access to PitchBook